News | Published:

A protein puzzle: Untangling the mysterious condition of amyloidosis

Nature Medicine volume 23, pages 266269 (2017) | Download Citation

  • A Correction to this article was published on 01 April 2017

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 23 March 2017

    In the March 2017 issue, the piece “A protein puzzle: Untangling the mysterious condition of amyloidosis” (Nat. Med. 23, 266–269, 2017) incorrectly stated that the FDA placed Ionis’ NEURO-TTR trial on hold. The FDA had placed a related trial called CARDIOTTR on hold after some patients in the NEURO-TTR trial developed complications. The error has been corrected in the HTML and PDF versions of this article.

Author information


  1. Shraddha Chakradhar is Nature Medicine's associate news editor in Boston.

    • Shraddha Chakradhar


  1. Search for Shraddha Chakradhar in:

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing